CBDNewsBreaks Archive - Page 18 of 278

FridayFeb 11, 2022 1:12 pm

CBDNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) to Be Evaluated for Potential Treatment Options for Multiple Conditions

Lexaria Bioscience Corp. (NASDAQ: LEXX) CEO Chris Bunka noted that Lexaria would continue to see significant milestones in utilizing its patented DehydraTECH drug delivery technology in 2022. “Calendar 2022 will continue to see significant milestones utilizing DehydraTECH-CBD for investigation of heart disease and hypertension; and separately, for oral nicotine delivery as an alternative to smoking… We are delighted to announce that DehydraTECH as an enhanced drug delivery platform will also be evaluated for characteristics and potential treatment options for hormone replacement, dementia, rheumatoid disease and diabetes,” a recent article quotes Bunka as saying. Lexaria received independent review board approval, marking…

FridayFeb 04, 2022 11:25 am

CBDNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Vertically Integrating Across Multiple States

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) reported a 93% year-over-year revenue growth from $6.1 million in Q3 2020 to $11.8 million in Q3 2021. According to RWB chairman and CEO Brad Rogers, the company made excellent progress in laying additional building blocks in its core operating states of Florida, Michigan and California to become more vertically integrated “where it will be most profitable.” In Florida, the company’s operations include active cannabis cultivation sites, an operational processing facility and a dispensary. In Michigan, RWB expects to be vertically integrated upon closing a pending acquisition of an investee whose…

WednesdayFeb 02, 2022 2:59 pm

CBDNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Blazing Trail in Defining Value of Rare Cannabinoids in Pharmaceutical Space

InMed Pharmaceuticals (NASDAQ: INM) is a trailblazer, a pioneer defining the value of rare cannabinoids in the pharmaceutical sector and just how integral they are in pushing the industry forward. The global cannabis market is experiencing tremendous growth, particularly considering there are over 100 known cannabinoids, including rare ones that are quickly taking over and will soon dominate the market. The potency of rare cannabinoids has given them powerful health benefits, hence their demand within the cosmetics, food and beverage, health and wellness, and pharmaceutical sectors. “InMed’s most advanced compound, INM-755, has already proven helpful in treating epidermolysis bullosa, a…

TuesdayFeb 01, 2022 1:49 pm

CBDNewsBreaks – BevCanna Enterprises Inc.’s (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) Leadership Position Recognized in Food and Beverage, Cannabis Products Categories

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health and wellness beverage and natural products company, recently announced it had been named as one of the 101 Top Food and Beverage Startups and Companies in Canada by Best Startup Canada. In addition, BevCanna was also recognized as one of the Top 101 Cannabis Startups and Companies in Canada, among innovators and growth companies within the Canadian cannabis industry. A recent article quotes BevCanna CEO Marcello Leone as saying, “This recognition of our leadership position within both the food and beverage and the cannabis products categories validates our strategy…

WednesdayJan 26, 2022 1:38 pm

CBDNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Strategically Pursuing Vertical Integration

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) is riding the popularity of its trademarked Platinum Vape to remarkable revenue growth, recording a 93% year-over-year increase in its recently released third-quarter financial report. “The financial results note that the majority of the company’s revenue comes from sales of cannabis finished products through third-party wholesaling to retailers, delivering quarterly revenue of $11.8 million and EBITDA of $5.9 million that reverses an EBITDA loss of $5.8 million in Q3 2020 for a gain of $11.9 million,” reads a recent article, which also includes comments by RWB chairman and CEO Brad Rogers…

TuesdayJan 25, 2022 2:28 pm

CBDNewsBreaks – Vantage Hemp Co. is in the Final Stages of its DMF Submissions

The usage of CBD as an active pharmaceutical ingredient is creating an overwhelming need for CBD manufacturers to identify their processes used in the manufacturing, packaging, and storing of pharmaceutical drug ingredients. On their way to set the industry bar, Colorado-based CBD manufacturer, Vantage Hemp Co., announces the company is in its final stages of its Drug Master File submissions to the US Food & Drug Administration. As one of the first CBD companies to file DMFs for all of its ingredients, Vantage is providing the FDA with confidential and detailed information about the quality and safety of its products. These submissions can…

FridayJan 21, 2022 2:20 pm

CBDNewsBreaks – Flora Growth Corp.’s (NASDAQ: FLGC) Products Ready for New International Markets

Flora Growth Corp. (NASDAQ: FLGC) is entering 2022 with momentum from the past year’s aggressive growth campaign for its global cannabis-derivative brand distribution of pharmaceuticals, cosmetics and nutraceuticals. While the COVID-19 pandemic has had a deleterious effect on the global sustainability agenda, Flora Growth has prioritized value-chain sustainability among each of its brands, acting at a local level to establish products that will have a beneficial effect on communities and the world at large. Flora’s core product, organic cannabis oil, comes from an inherently sustainable process at the company’s cultivation site in central Colombia. “The company recently began filling the…

FridayJan 14, 2022 12:50 pm

CBDNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Leveraging DehydraTECH(TM) to Deliver More Effective Oral Medicine

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator of drug delivery platforms, is increasing the effectiveness of orally administered drugs. With oral absorption being the most convenient and widely used route for taking medications, decades of research have advanced the understanding of critical factors controlling oral bioavailability. Scientists are now better understanding the physiological function and formulation functionality that has been used in designing improved and more desirable oral medicine delivery through extensive research. Lexaria is accomplishing this through its patented DehydraTECH(TM) technology. “DehydraTECH improves the way that active pharmaceutical ingredients (‘APIs’) make their way into the bloodstream. This is…

FridayJan 14, 2022 12:33 pm

CBDNewsBreaks – Marijuana Company of America Inc.’s (MCOA) Strong Financial Performance Reflects Successful Diversification Capabilities, Organic Growth

Marijuana Company of America (OTC: MCOA) is uniquely positioned to benefit from the cannabis market’s growth and associated opportunities as more states and countries worldwide push for the legalization of cannabis. MCOA offers diverse operations that include its cDistro distribution company, as well as hempsmart(TM) and VBF brands, a premium CBD company and a cannabis nursery cultivation facility in Salinas, California, respectively. In addition, the company is building its portfolio of investments and joint ventures, representing the highest standards of professionalism and integrity in the legal cannabis and industrial hemp markets. “MCOA recently reported a significant milestone, reaching the highest…

ThursdayJan 13, 2022 3:05 pm

CBDNewsBreaks – BevCanna Enterprises Inc.’s (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) Strong Financial Results Evidence Continued Execution, Brands’ Impact on Market

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health and wellness beverage and natural products company, recently released its unaudited financial results for the fiscal quarter ended Sept. 30, 2021. The company saw revenues increase by more than 1,000% to $1.1 million with a gross profit of $356,168, a significant turnaround from the loss of $40,280 recorded in Q3 2020. A recent article quotes BevCanna Chief Financial Officer John Campbell as saying, “As we closed out the third quarter, we delivered impressive revenue growth of more than 1,000%, achieving $1.1 million in sales, compared to $94,000 in the…

News and publishing service for CBD related companies

Contact us: 512.354.7000

CannabisNewsBreaks